echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Chinese scholars have made progress in the study of blood pressure reduction goals in elderly hypertensive patients

    Chinese scholars have made progress in the study of blood pressure reduction goals in elderly hypertensive patients

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    With funding from the National Natural Science Foundation of China (approval numbers: 81630014, 8182002) and other funding, the research team of Professor Cai Jun from Fuwai Hospital of the Chinese Academy of Medical Sciences has made new progress in the study of blood pressure reduction targets for elderly hypertensive patients in China.


    Hypertension is one of the chronic diseases with the largest number of patients worldwide, and an important risk factor for the occurrence, development and death of cardiovascular diseases


    The STEP study was launched in 2017.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.